These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23482449)

  • 41. Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery.
    Ballantyne GH
    Obes Surg; 2006 Jun; 16(6):795-803. PubMed ID: 16756746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake.
    Kanatani A; Ishihara A; Asahi S; Tanaka T; Ozaki S; Ihara M
    Endocrinology; 1996 Aug; 137(8):3177-82. PubMed ID: 8754736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.
    Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
    Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of taste responsiveness by the satiation hormone peptide YY.
    La Sala MS; Hurtado MD; Brown AR; Bohórquez DV; Liddle RA; Herzog H; Zolotukhin S; Dotson CD
    FASEB J; 2013 Dec; 27(12):5022-33. PubMed ID: 24043261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor?
    Haynes AC; Arch JR; Wilson S; McClue S; Buckingham RE
    Regul Pept; 1998 Sep; 75-76():355-61. PubMed ID: 9802429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys.
    Moran TH; Smedh U; Kinzig KP; Scott KA; Knipp S; Ladenheim EE
    Am J Physiol Regul Integr Comp Physiol; 2005 Feb; 288(2):R384-8. PubMed ID: 15388494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gut hormone PYY(3-36) physiologically inhibits food intake.
    Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; Low MJ; Ghatei MA; Cone RD; Bloom SR
    Nature; 2002 Aug; 418(6898):650-4. PubMed ID: 12167864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner.
    Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M
    J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide.
    Stanley S; Wynne K; Bloom S
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G693-7. PubMed ID: 15068960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive.
    Arusoglu G; Koksal G; Cinar N; Tapan S; Aksoy DY; Yildiz BO
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4475-82. PubMed ID: 24001751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gut hormones as peripheral anti obesity targets.
    Small CJ; Bloom SR
    Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
    Kanatani A; Ishihara A; Iwaasa H; Nakamura K; Okamoto O; Hidaka M; Ito J; Fukuroda T; MacNeil DJ; Van der Ploeg LH; Ishii Y; Okabe T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 2000 May; 272(1):169-73. PubMed ID: 10872822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of peptide YY in 5-fluorouracil-induced reduction of dietary intake.
    Sakai H; Kai Y; Takase K; Sato K; Kimura M; Tabata S; Yaegashi M; Sato F; Yomoto T; Narita M
    Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):753-9. PubMed ID: 27130783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peptide YY 3-36 and pancreatic polypeptide differentially regulate hypothalamic neuronal activity in mice in vivo as measured by manganese-enhanced magnetic resonance imaging.
    Hankir MK; Parkinson JR; Minnion JS; Addison ML; Bloom SR; Bell JD
    J Neuroendocrinol; 2011 Apr; 23(4):371-80. PubMed ID: 21251093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents.
    Stock S; Leichner P; Wong AC; Ghatei MA; Kieffer TJ; Bloom SR; Chanoine JP
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2161-8. PubMed ID: 15657373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats.
    Chelikani PK; Haver AC; Reeve JR; Keire DA; Reidelberger RD
    Am J Physiol Regul Integr Comp Physiol; 2006 Feb; 290(2):R298-305. PubMed ID: 16210414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: cholinergic mechanisms.
    Wager-Pagé SA; Raizada E; Veale W; Davison JS
    Can J Physiol Pharmacol; 1993; 71(10-11):768-75. PubMed ID: 8143235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of peptide YY in appetite regulation and obesity.
    Karra E; Chandarana K; Batterham RL
    J Physiol; 2009 Jan; 587(1):19-25. PubMed ID: 19064614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
    Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
    Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.